FILANA THERAPEUTICS, INC.

Nasdaq:SAVA

Pharmaceutical Preparations·AUSTIN, TX

CEO

Barry Richard

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/3/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

22 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/3/25	Q1 FY2025	→
1/7/25	Q4 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

58 shown

Filed	Type	Description
3/10/26	Reg FD	Amendments to Articles of Incorporation or Bylaws	→
2/19/26	Reg FD	Regulation FD Disclosure	→
12/23/25	Agreement	Entry into a Material Definitive Agreement	→
12/22/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/18/25	Other	Other Events	→
12/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

34 shown

Filed	Form	Description
12/5/25	424B2	424B2	→
11/13/25	S-3	S-3	→
4/14/25	ARS	ARS	→
3/22/24	ARS	ARS	→
1/3/24	424B2	424B2	→
5/1/23	424B5	424B5	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

8-K

Mar 10, 2026

0001437749-26-007422FORM 8-K

Mar 10, 2026

365.3 KB

8-K

Feb 19, 2026

0001171843-26-000922FORM 8-K

Feb 19, 2026

218.1 KB

8-K

Dec 23, 2025

0001437749-25-038605FORM 8-K

Dec 19, 2025

154.8 KB

8-K/A

Dec 22, 2025

0001437749-25-038544FORM 8-K/A

Oct 21, 2025

160.7 KB

8-K

Dec 18, 2025

0001437749-25-038313FORM 8-K

Dec 15, 2025

154.8 KB

8-K

Dec 17, 2025

0001437749-25-038157FORM 8-K

Dec 12, 2025

155.8 KB

EFFECT

Dec 5, 2025

9999999995-25-003554

—

1.8 KB

424B2

Dec 5, 2025

0001493152-25-026408424B2

—

639.0 KB

8-K

Dec 3, 2025

0001437749-25-036710FORM 8-K

Nov 26, 2025

156.2 KB

Nov 25, 2025

0001437749-25-036321FORM 4

Nov 24, 2025

4.2 KB

Nov 24, 2025

0001437749-25-036125FORM 4

Nov 20, 2025

4.9 KB

Nov 20, 2025

0001437749-25-035882FORM 4

Nov 19, 2025

4.9 KB

S-3

Nov 13, 2025

0001493152-25-022066S-3

—

1.5 MB

10-Q

Nov 12, 2025

0001437749-25-034427FORM 10-Q

Sep 30, 2025

5.2 MB

8-K

Nov 12, 2025

0001171843-25-007222FORM 8-K

Nov 12, 2025

283.3 KB

8-K

Oct 24, 2025

0001437749-25-031674FORM 8-K

Oct 23, 2025

153.9 KB

Oct 22, 2025

0001437749-25-031540FORM 4

Oct 21, 2025

5.0 KB

Oct 22, 2025

0001437749-25-031538FORM 3

Oct 21, 2025

14.6 KB

8-K

Oct 22, 2025

0001437749-25-031466FORM 8-K

Oct 21, 2025

206.8 KB

Oct 2, 2025

0001437749-25-030348FORM 4

Sep 30, 2025

4.3 KB

Sep 23, 2025

0001437749-25-029725FORM 4

Sep 22, 2025

4.9 KB

Sep 22, 2025

0001437749-25-029586FORM 4

Sep 18, 2025

8.7 KB

8-K

Sep 8, 2025

0001437749-25-028530FORM 8-K

Sep 8, 2025

6.5 MB

10-Q

Aug 14, 2025

0001437749-25-026686FORM 10-Q

Jun 30, 2025

5.0 MB

8-K

Aug 14, 2025

0001171843-25-005406FORM 8-K

Aug 14, 2025

283.6 KB

25 filings shown

Filed	Form	Description
4/14/25	DEF 14A	DEF 14A	→
4/3/25	PRE 14A	FORM PRE 14A	→
3/26/24	DEF 14A	DEF 14A	→
3/27/23	DEF 14A	DEF 14A	→
3/16/23	PRE 14A	PRE 14A	→
3/24/22	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
12/5/25	EFFECT	EFFECT	→
7/29/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/16/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/2/24	144	144	→
11/29/24	144	144	→
11/26/24	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓

FILANA THERAPEUTICS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/25/25	4	4	→
11/24/25	4	4	→
11/20/25	4	4	→
10/22/25	4	4	→
10/22/25	3	FORM 3	→
10/2/25	4	4	→
↓